Jaguar Health (JAGX) Cash from Operations Growth (1y) (2015 - 2026)
Jaguar Health (JAGX) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 356.73% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 74.39% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 3.23% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 158.60% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 220.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220.73% |
| Dec 31, 2025 | 29.87% |
| Sep 30, 2025 | 26.05% |
| Jun 30, 2025 | 24.17% |
| Mar 31, 2025 | -3.79% |
| Dec 31, 2024 | -5.03% |
| Sep 30, 2024 | 6.61% |
| Jun 30, 2024 | 9.78% |
| Mar 31, 2024 | 29.14% |
| Dec 31, 2023 | -16.00% |
| Sep 30, 2023 | 20.39% |
| Jun 30, 2023 | 13.40% |
| Mar 31, 2023 | -29.24% |
| Dec 31, 2022 | 28.02% |
| Sep 30, 2022 | 9.57% |
| Jun 30, 2022 | -5.55% |
| Mar 31, 2022 | -14.71% |
| Dec 31, 2021 | -119.72% |
| Sep 30, 2021 | -223.12% |
| Jun 30, 2021 | -147.55% |